Artwork

Вміст надано Sheree Dibiase. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Sheree Dibiase або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Player FM - додаток Podcast
Переходьте в офлайн за допомогою програми Player FM !

Revolutionizing Women's Health: Non-Drug Therapy for Yeast and Bacterial Vaginosis | Innovative Microbiocidal Light Device | Potential for Telemedicine Integration | Addressing Unmet Needs | Gregg Klang

53:02
 
Поширити
 

Manage episode 433921217 series 3521691
Вміст надано Sheree Dibiase. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Sheree Dibiase або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.

Gregg Klang, Femtech founder of CERN Corporation, discusses the development of a microbiocidal light device for yeast and bacterial vaginosis treatment. The device offers an alternative to drug-based therapies, catering to those who prefer non-medication options. Greg explains the status of development, including human trials, in vitro and ex vivo testing, and animal testing for safety. Tune in to learn more about his journey into women's health tech innovation with CERN Corporation.

Timestamps

  • (01:20) CERN Corporation was founded to develop a non-drug therapy for yeast and bacterial vaginosis, targeting those for whom drug-based therapies are not effective or desired.
  • (10:23) The CERN device uses microbiocidal light therapy to target key pathogens associated with yeast and bacterial vaginosis, providing a non-drug treatment option.
  • (16:39) The CERN device is designed to accommodate different sizes to ensure comfort and effectiveness for women with varying pelvic floor conditions, including hypertonicity.
  • (32:26) Physicians are impressed by the CERN device's approach and potential benefits for patients, expressing interest in its availability and integration into their practices.
  • (44:24) The founder of CERN Corporation emphasizes the importance of the team's support and expertise in driving the development and success of the non-drug therapy device.

Host Bio

This podcast is hosted by Sheree Dibiase, PT ICLM. She is a nationally recognized women's health physical therapist who owns seven private clinics — one of the biggest networks in the US. She has spent 30+ years practicing in the oncology, pelvic floor, and prenatal postpartum healthcare spaces. She was also a professor for seven years a Loma Linda University where she taught kinesiology.

Brought to you by...

https://lakecitypt.com/ - Women's health physical therapy.

https://pelvicfloorpro.com/ - Pelvic floor physical therapy from home.

Keywords

Femtech, Women's Health, Pelvic Floor, Breast Cancer, Prenatal & postpartum

  continue reading

41 епізодів

Artwork
iconПоширити
 
Manage episode 433921217 series 3521691
Вміст надано Sheree Dibiase. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Sheree Dibiase або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.

Gregg Klang, Femtech founder of CERN Corporation, discusses the development of a microbiocidal light device for yeast and bacterial vaginosis treatment. The device offers an alternative to drug-based therapies, catering to those who prefer non-medication options. Greg explains the status of development, including human trials, in vitro and ex vivo testing, and animal testing for safety. Tune in to learn more about his journey into women's health tech innovation with CERN Corporation.

Timestamps

  • (01:20) CERN Corporation was founded to develop a non-drug therapy for yeast and bacterial vaginosis, targeting those for whom drug-based therapies are not effective or desired.
  • (10:23) The CERN device uses microbiocidal light therapy to target key pathogens associated with yeast and bacterial vaginosis, providing a non-drug treatment option.
  • (16:39) The CERN device is designed to accommodate different sizes to ensure comfort and effectiveness for women with varying pelvic floor conditions, including hypertonicity.
  • (32:26) Physicians are impressed by the CERN device's approach and potential benefits for patients, expressing interest in its availability and integration into their practices.
  • (44:24) The founder of CERN Corporation emphasizes the importance of the team's support and expertise in driving the development and success of the non-drug therapy device.

Host Bio

This podcast is hosted by Sheree Dibiase, PT ICLM. She is a nationally recognized women's health physical therapist who owns seven private clinics — one of the biggest networks in the US. She has spent 30+ years practicing in the oncology, pelvic floor, and prenatal postpartum healthcare spaces. She was also a professor for seven years a Loma Linda University where she taught kinesiology.

Brought to you by...

https://lakecitypt.com/ - Women's health physical therapy.

https://pelvicfloorpro.com/ - Pelvic floor physical therapy from home.

Keywords

Femtech, Women's Health, Pelvic Floor, Breast Cancer, Prenatal & postpartum

  continue reading

41 епізодів

Усі епізоди

×
 
Loading …

Ласкаво просимо до Player FM!

Player FM сканує Інтернет для отримання високоякісних подкастів, щоб ви могли насолоджуватися ними зараз. Це найкращий додаток для подкастів, який працює на Android, iPhone і веб-сторінці. Реєстрація для синхронізації підписок між пристроями.

 

Короткий довідник

Слухайте це шоу, досліджуючи
Відтворити